Diabetes Technology in T1D Youth &nb sp;
| The PROactive is a meta-analysis published regarding whether pioglitazone reduces the risk of macrovascular complications in patients with type 2 diabetes mellitus (DM) and high risk for macrovascular complications compared to placebo. |
|
|
In the SWEET project experience, a large cohort of patients was started on either an insulin pump, glucose sensor, or both to compare the HbA1c levels and weight gain while on their new therapy. |
| |
| |
| A retrograde cohort study suggests that metabolic and acid base parameters may be useful in differentiating typical diabetic ketoacidosis DKA from Hyperglycemic Ketoacidosis related to cannabis hyperemesis syndrome in patients with type 1 diabetes. |
| |
|
|
|